Clinical trial
Genetics of the Acute Response to Oral Semaglutide (GAROS)
NCT05340868 is registered in ClinicalTrials.gov with Medical University of Bialystok as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genetics of the Acute Response to Oral Semaglutide (GAROS)
- Lead sponsor
- Medical University of Bialystok
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 1, 2022
- Completion date
- December 31, 2025
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
obesity, prediabetes, prediabetic state